Description: ConjuChem creates novel, next-generation medicines using unique, long-acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation platforms called Drug Affinity Complex (DAC tm) and Preformed Conjugate-Drug Affinity Complex (PC-DAC tm).
llc (3005) therapeutic peptides (4) conjuchem biotechnologies inc. (1) conjuchem (1) drug affinity complex (1) dac tm (1) preformed conjugate-drug affinity complex (1) pc-dac tm (1) cjc-1134-pc (1) exendin-4 (1)
ConjuChem creates novel, next-generation medicines using unique, long-acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation platforms called Drug Affinity Complex (DAC™) and Preformed Conjugate-Drug Affinity Complex (PC-DAC™). When applied to a given peptide, DAC™ and PC- DAC™ can create new drugs with similar therapeutic activities but with significantly longer durations of activity and improved safety profiles.